GlaxoSmithKline plc (GSK) Given "Neutral" Rating at Credit Suisse Group
's stock had its "neutral" rating restated by stock analysts at Credit Suisse Group in a report issued on Thursday. They presently have a GBX 1,750 price target on the stock.
from Biotech News
0 Comments